1 |
王佳林,王重阳,李杨,等.饮食诱导非酒精性脂肪性肝病动物模型的研究进展[J].中国比较医学杂志,2023,33(12):93-96.
|
|
WANG J L, WANG C Y, LI Y, et al.. Advances in animal models of diet-induced non-alcoholic fatty liver disease[J]. Chin. J. Comp. Med., 2023, 33(12): 93-96.
|
2 |
ZHOU J, ZHANG N, ALDHAHRANI A, et al.. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation[J/OL]. Front. Immunol., 2022, 13: 956688[2024-04-07]. .
|
3 |
邹华,游志鹏,吴晓坚.葛根素对糖尿病视网膜病变损伤的保护作用及机制研究进展[J].国际眼科杂志,2023,23(8):1295-1298.
|
|
ZOU H, YOU Z P, WU X J. Research progress on the protective effect and mechanism of puerarin on diabetic retinopathy[J]. Int. Eye Sci., 2023, 23(8): 1295-1298.
|
4 |
齐大河,马桦,陈媛媛,等.葛根素治疗血管性痴呆的作用机制研究进展[J].中国中药杂志,2023,48(22):5993-6002.
|
|
QI D H, MA H, CHEN Y Y, et al.. Research progress in mechanism of puerarin in treating vascular dementia[J]. China J. Chin. Mater. Med., 2023, 48(22): 5993-6002.
|
5 |
施凯舜,徐峥,岳跃兵,等.葛根素对非酒精性脂肪肝小鼠糖脂代谢的影响及机制[J].浙江医学,2023,45(19):2036-2040.
|
|
SHI K S, XU Z, YUE Y B, et al.. Effect of puerarin on glucose and lipid metabolism in non-alcoholic fatty liver rats[J]. Zhejiang Med., 2023, 45(19): 2036-2040.
|
6 |
倪雪桐,王若羲,张晶,等.非酒精性脂肪性肝病、代谢相关脂肪性肝病与心血管疾病关联的国内外研究进展[J].中国全科医学,2024,27(16):2033-2038.
|
|
NI X T, WANG R X, ZHANG J, et al.. Research progress in the correlation of non-alcoholic fatty liver disease and metabolic-associated fatty liver disease with cardiovascular disease in China and abroad[J]. Chin. Gen. Prac., 2024, 27(16): 2033-2038.
|
7 |
高杰清,薛婧,李冰,等.间充质干细胞治疗2型糖尿病小鼠非酒精性脂肪肝的机制研究[J].解放军医学院学报,2021,42(12):1298-1303.
|
|
GAO J Q, XUE J, LI B, et al.. Mechanism of mesenchymal stem cells in attenuating non-alcoholic fatty liver disease in diabetic mice[J]. Acad. J. Chin. PLA Med. Sch., 2021, 42(12): 1298-1303.
|
8 |
LI Y, WANG C, JIN Y, et al.. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats[J/OL]. Biomed. Pharmacother., 2020, 126: 109734[2024-04-07]. .
|
9 |
李芳,陈华伟,钟军华,等.槲皮苷对非酒精性脂肪肝大鼠肝纤维化和炎症作用研究[J].中国临床药理学杂志,2023,39(12):1753-1757.
|
|
LI F, CHEN H W, ZHONG J H, et al.. Effect of quercitrin on liver fibrosis and inflammation in non-alcoholic fatty liver rats[J]. Chin. J. Clin. Pharmacol., 2023, 39(12): 1753-1757.
|
10 |
凤渐舒.人参二醇通过激活β2受体诱导线粒体生物合成防治非酒精性脂肪肝[D].长春:吉林大学,2023.
|
11 |
王艳,宋丽.加味茵陈蒿汤联合针刺对非酒精性脂肪肝患者肠道菌群、氧化应激及细胞因子的影响[J].现代中西医结合杂志,2023,32(8):1119-1122+1126.
|
12 |
SUN C, ZHANG J, HOU J, et al.. Induction of autophagy via the PI3K/Akt/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice[J/OL]. Biomed. Pharmacother., 2023, 1(157): 114005[224-04-07]. .
|
13 |
LI Q, LIU W, ZHANG H, et al.. α-D-1,3-glucan from radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites[J/OL]. Carbohydr. Polym., 2023, 299:120197[224-04-07]. .
|
14 |
PHAM T H, LEE G H, JIN S W, et al.. Puerarin attenuates hepatic steatosis via G-protein-coupled estrogen receptor-mediated calcium and SIRT1 signaling pathways[J]. Phytother. Res., 2022, 36(9): 3601-3618.
|
15 |
XU S, YE B, LI J, et al.. Astragalus mongholicus powder, a traditional Chinese medicine formula ameliorate type 2 diabetes by regulating adipoinsular axis in diabetic mice[J/OL]. Front. Pharmacol., 2022, 13: 973927[224-04-07]. .
|